Effect of Supplementation with Vitamin D3 and Calcium on Quantitative Ultrasound of Bone in Elderly Institutionalized Women: A Longitudinal Study

被引:0
|
作者
M. A. Krieg
A. F. Jacquet
M. Bremgartner
S. Cuttelod
D. Thiébaud
P. Burckhardt
机构
[1] Department of Internal Medicine,
[2] University Hospital,undefined
[3] Lausanne,undefined
[4] Novartis Pharma,undefined
[5] Basle;,undefined
[6] Vaudoise Association of Nursing Homes,undefined
[7] Pully,undefined
[8] Switzerland,undefined
来源
关键词
Key words:Institutionalized elderly – Secondary hyperparathyroidism – Ultrasound of bone – Vitamin D deficiency;
D O I
暂无
中图分类号
学科分类号
摘要
Supplementation of elderly institutionalized women with vitamin D and calcium decreased hip fractures and increased hip bone mineral density. Quantitative ultrasound (QUS) measurements can be performed in nursing homes, and easily repeated for follow-up. However, the effect of the correction of vitamin D deficiency on QUS parameters is not known. Therefore, 248 institutionalized women aged 62–98 years were included in a 2-year open controlled study. They were randomized into a treated group (n = 124), receiving 440 IU of vitamin D3 combined with 500 mg calcium (1250 mg calcium carbonate, Novartis) twice daily, and a control group (n = 124). One hundred and three women (42%), aged 84.5 ± 7.5 years, completed the study: 50 in the treated group, 53 in the controls. QUS of the calcaneus, which measures BUA (broadband ultrasound attenuation) and SOS (speed of sound), and biochemical analysis were performed before and after 1 and 2 years of treatment. Only the results of the women with a complete follow-up were taken into account. Both groups had low initial mean serum 25-hydroxyvitamin D levels (11.9 ± 1.2 and 11.7 ± 1.2 mg/l; normal range 6.4–40.2 mg/l) and normal mean serum parathyroid hormone (PTH) levels (43.1 ± 3.2 and 44.6 ± 3.5 ng/l; normal range 10–70 ng/l, normal mean 31.8 ± 2.3 ng/l). The treatment led to a correction of the metabolic disturbances, with an increase in 25-hydroxyvitamin D by 123% (p50.01) and a decrease in PTH by 18% (p50.05) and of alkaline phosphatase by 15% (p50.01). In the controls there was a worsening of the hypovitaminosis D, with a decrease of 25-hydroxyvitamin D by 51% (p50.01) and an increase in PTH by 51% (p50.01), while the serum calcium level decreased by only 2% (p5 0.01). After 2 years of treatment BUA increased significantly by 1.6% in the treated group (p50.05), and decreased by 2.3% in the controls (p50.01). Therefore, the difference in BUA between the treated subjects and the controls (3.9%) was significant after 2 years (p50.01). However, SOS decreased by the same amount in both groups (approximately 0.5%). In conclusion, BUA, but not SOS, reflected the positive effect on bone of supplementation with calcium and vitamin D3 in a population of elderly institutionalized women.
引用
收藏
页码:483 / 488
页数:5
相关论文
共 50 条
  • [21] The efficacy of calcitriol and vitamin D3 supplementation on calcium metabolism and bone turnover markers in Shanghai postmenopausal women
    Zhang, Hao
    Huang, Qi-ren
    Zhang, Zhen-lin
    BONE, 2010, 47 : S427 - S427
  • [22] Effect of vitamin D3 and calcium carbonate supplementation on muscle strength in postmenopausal women living with HIV
    Yin, Michael T.
    Bucovsky, Mariana
    Williams, John
    Brunjes, Danielle
    RoyChoudhury, Arindam
    Colon, Ivelisse
    Ferris, David C.
    Olender, Susan
    Schulze, P. Christian
    Sharma, Anjali
    Zeana, Cosmina
    Zingman, Barry
    Shane, Elizabeth
    ANTIVIRAL THERAPY, 2020, 25 (08) : 411 - 418
  • [23] Effect of calcium and vitamin D supplementation on bone loss in postmenopausal Chinese women: A comparative study
    Huang, OR
    Lu, JH
    Zhou, Q
    Liu, YJ
    Wang, QH
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S183 - S184
  • [24] Calcium vitamin D3 supplementation in clinical practice: Side effect and satisfaction
    Sanaei M.
    Banasiri M.
    Shafiee G.
    Rostami M.
    Alizad S.
    Ebrahimi M.
    Larijani B.
    Heshmat R.
    Journal of Diabetes & Metabolic Disorders, 15 (1):
  • [25] Calcium vitamin D3 supplementation in clinical practice: side effect and satisfaction
    Maryam Sanaei
    Mohammad Banasiri
    Gita Shafiee
    Mahsa Rostami
    Saba Alizad
    Mehdi Ebrahimi
    Bagher Larijani
    Ramin Heshmat
    Journal of Diabetes & Metabolic Disorders, 15 (1):
  • [26] Calcium and vitamin D3 supplements in calcium and vitamin D3 sufficient early postmenopausal healthy women
    J Tfelt-Hansen
    O Tørring
    European Journal of Clinical Nutrition, 2004, 58 : 1420 - 1424
  • [27] Calcium and vitamin D3 supplements in calcium and vitamin D3 sufficient early postmenopausal healthy women
    Tfelt-Hansen, J
    Torring, O
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2004, 58 (10) : 1420 - 1424
  • [28] Sclerostin in Institutionalized Elderly Women: Associations with Quantitative Bone Ultrasound, Bone Turnover, Fractures, and Mortality
    Amrein, Karin
    Dobnig, Harald
    Wagner, Doris
    Piswanger-Soelkner, Claudia
    Pieber, Thomas R.
    Pilz, Stefan
    Tomaschitz, Andreas
    Dimai, Hans Peter
    Fahrleitner-Pammer, Astrid
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2014, 62 (06) : 1023 - 1029
  • [29] Is daily supplementation with vitamin D2 equivalent to daily supplementation with vitamin D3 in the elderly?
    Seijo, Mariana
    Mastaglia, Silvina
    Brito, Graciela
    Somoza, Julia
    Oliveri, Beatriz
    MEDICINA-BUENOS AIRES, 2012, 72 (03) : 195 - 200
  • [30] Effect of Vitamin D3 supplementation on symptomatic uterine leiomyoma in women with Hypovitaminosis D
    Suneja, Amita
    Faridi, Fahmina
    Bhatt, Shuchi
    Guleria, Kiran
    Mehndiratta, Mohit
    Sharma, Richa
    JOURNAL OF MID-LIFE HEALTH, 2021, 12 (01) : 53 - 60